lobenzarit has been researched along with Carditis in 3 studies
lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus B3 myocarditis." | 7.68 | Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "The aim of this study is to test the therapeutic efficacy of immunomodulation with lobenzarit disodium (CCA) upon coxsackievirus B3 (CB3) myocarditis." | 7.68 | The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "Lobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number and function." | 5.28 | Effects of lobenzarit on murine acute viral myocarditis. ( Kanda, T; Murata, K; Suzuki, T; Yokoyama, T, 1992) |
| "The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus B3 myocarditis." | 3.68 | Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "The aim of this study is to test the therapeutic efficacy of immunomodulation with lobenzarit disodium (CCA) upon coxsackievirus B3 (CB3) myocarditis." | 3.68 | The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "Lobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number and function." | 1.28 | Effects of lobenzarit on murine acute viral myocarditis. ( Kanda, T; Murata, K; Suzuki, T; Yokoyama, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishimoto, C | 2 |
| Takada, H | 2 |
| Kuroki, Y | 2 |
| Matsushita, I | 2 |
| Hiraoka, Y | 2 |
| Kurokawa, M | 2 |
| Ochiai, H | 2 |
| Sasayama, S | 2 |
| Yokoyama, T | 1 |
| Kanda, T | 1 |
| Suzuki, T | 1 |
| Murata, K | 1 |
3 other studies available for lobenzarit and Carditis
| Article | Year |
|---|---|
Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Immunosuppressive Agents; Male; Mice; Mice | 1993 |
The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Coxsackievirus Infections; Enterovirus B, Human; | 1993 |
Effects of lobenzarit on murine acute viral myocarditis.
Topics: Adjuvants, Immunologic; Animals; Blood Cell Count; Encephalomyocarditis virus; Enterovirus Infection | 1992 |